Driehaus Capital Management LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 938206
Chicago, IL
Position in XERS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,235,892
-$18,161,558 QoQ
Shares Held
902,740
-69.7% QoQ
Ownership
0.495%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Driehaus Capital Management LLC holds $285,823,124 across 6 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,299,054 | $94,330,185 | |
| 2 | ALKS |
Alkermes plc.
|
1,238,809 | $64,913,591 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
3,036,970 | $54,543,981 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
718,199 | $45,928,826 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
650,940 | $16,019,633 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
121,852 | $10,086,908 |
All Filings in XERS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,235,892 | 902,740 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,397,450 | 2,980,567 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,319,710 | 2,619,129 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,671,920 | 2,071,075 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,749,354 | 1,411,540 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,013,710 | 594,015 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||